Judge Says Aggregation of Medical Monitoring Costs Inappropriate, Remands Cases




LOS ANGELES - A federal judge in California has remanded two Vioxx-related medical monitoring class actions, determining that defendant Merck & Co. failed to demonstrate that the damages sought by plaintiffs - either current or prospective - would exceed the jurisdictional limit. Pargar v. Merck & Company, Inc., et al., No. 04-9206; Bloom-Thomen v. Merck & Company, Inc., et al., No. 04-9245 (C.D. Calif.).

In orders issued Jan. 3, Judge John F. Walter of the U.S. District Court for the Central District of California rejected Merck's argument that the cost to start up a medical monitoring fund for plaintiffs who …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference

March 26, 2025 - Charlotte, NC
Omni Charlotte Hotel

MORE DETAILS



HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference

April 08, 2025 - Long Beach, CA
The Westin Long Beach

MORE DETAILS